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ARTIGO ORIGINAL 
FREQUENCY OF HEPATIC STEATOSIS IN A RADIOLOGY CLINIC IN 
PALMAS 
David Ailton Dias Filho¹, Wellington Andraus², Paulo Martins Reis Júnior³. 
ABSTRACT 
Introduction: Recent studies suggest that hepatic steatosis is a worldwide 
distribution pathology that can progress to chronic liver disease with a highly 
unfavorable outcome resulting in the need for liver transplantation. That’s why 
early diagnosis is important. The liver biopsy’s considered a "gold standard" in its 
diagnosis, but the use of ultrasonography helps to detect steatosis in a non-
invasive manner and is a very accessible method for the population. Objectives: To 
evaluate the frequency of steatosis in patients treated at a radiological clinic in 
Palmas using abdominal ultrasonography; observing its distribution in genders and 
age groups and its difference between 2010 and 2016. Methods: It was used 
ultrasound reports of abdomen of 3.222 patients made in 2010 and of 2.346 
patients made in 2016. A longitudinal analysis was performed, between these two 
years, regarding the frequency of hepatic steatosis at the people and also between 
the genders and the age groups. Results: In 2010, 25,67% of people had hepatic 
steatosis in the ultrasound report, while in 2016 were 31,67%. In 2010, of the total 
number of people with steatosis, 52,48% were women and 47,52% were men; 
however in 2016, 51,94% were women and 48,06% were men. Regarding the age 
groups, in both periods, as in men and in women, steatosis was lower at the 
extremes of age and more frequent around the 5th to 7th decades of life. 
Discussion: The frequency of hepatic steatosis has increased in the period from 
2010 to 2016. It was, as seen in the literature, quite high in the 5th and 6th 
decades of life, besides being more frequent in females. Unlike 2010, in 2016 
begins to have children under 20 with signs of steatosis. Conclusion: In the year 
2010 the frequency of hepatic steatosis was 25,67%, whereas in 2016 it was 
31,84%.    
Keywords: Steatosis; ultrasonography; liver. 
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INTRODUCTION 
Hepatic steatosis is a pathological condition which 
causes lipid metabolism abnormalities1, which leads to its 
significant accumulation, mainly of triglycerides, in the 
cytoplasm of hepatocytes exceeding 5% of liver weight2-12. 
This accumulation in the hepatic parenchyma may occur in a 
diffuse or focal form causing alterations of the liver function 
and damages to the hepatic tissues13,14. It can have several 
etiologies, mainly alcoholism, hepatitis C virus infection and 
non-alcoholic steatosis, which is related to genetic factors, life 
habits and mostly obesity3,7,12. Over time, it can present 
evolutionary patterns such as: steatohepatitis, advanced 
fibrosis, cirrhosis and hepatocellular carcinoma, which 
increases the likelihood of patients needing a liver transplant, 
therefore it is important an early diagnosis of hepatic 
steatosis2,6,15-18. 
Steatosis is a worldwide distribution disease19, 
occurring in 10% to 24% of the population in several 
countries13, and its prevalence is higher in the 5th and 6th 
decade of life, female population, obese people, those with 
type 2 diabetes mellitus or with metabolic syndrome such as 
dyslipidemia, abdominal obesity, hyperinsulinemia and insulin 
resistance2,5,20. However, it may be present in male, non-
diabetic or lean individuals12. In addition, their frequency has 
increased in children, thanks to the increase in childhood 
obesity12,13, and may progress to liver cirrhosis in some of 
these pediatric patients by the time they reach adulthood18. 
It’s important to do the anamnesis, physical 
examination, laboratory tests, imaging tests and 
histopathological evaluation in order to diagnose steatosis7. 
The "gold standard" for its diagnosis is the histopathological 
evaluation by liver biopsy, because it allows a better staging of 
the disease and also allows access to morphology of the 
lesion1,7,21-23. However, its use is limited and shouldn’t be used 
as a screening tool8, because it has a sampling error, high cost 
and adverse events, and can’t be used with the intention of 
performing a research7,22. Through the biopsy, the 
accumulation of fat in the liver parenchyma is observed. In 
this way, steatosis can be classified as: Grade 0, when the 
accumulation is less than 5% of the liver weight; Grade 1, 
when it is from 5% to 33% of its weight; Grade 2, with 
accumulation above 33%, but below 66%; and Grade 3, when 
the accumulation is greater than 66%18,21. 
Imaging tests, such as magnetic resonance imaging 
(MRI), computed tomography (CT), and ultrasonography 
(USG), are also efficient for detecting liver fat and may aid in 
the need for a biopsy7,12,21. The CT scan is less sensitive than 
USG11, it has a higher cost and uses ionizing radiation to 
perform it3. Both CT and USG examinations are less sensitive 
than those of MRI12, but nuclear resonance, even though it’s 
the most efficient noninvasive method to detect fatty 
infiltration in the liver, is a costly procedure3. Therefore, due 
to the cost of the examination and the modest increase in 
accuracy, USG of the abdomen has been the most widely used 
imaging method in the clinical practice for the diagnosis of 
hepatic steatosis12,24, it also provides early diagnosis in 
patients who are still asymptomatic3, and has  a more 
affordable cost and the non-use radiation in its 
realization2,24,25. 
Abdominal ultrasound can evaluate liver shape, 
border characteristics, intrahepatic vessel arrangement, 
contour, biometry, liver parenchyma characteristics 
(echogenicity, attenuation, echotexture)2,3,23. In cases of 
steatosis, attenuation of the sound beam, gradual increase of 
parenchyma echogenicity in a diffuse form, and echogenicity 
discrepancy between the liver and the kidney are 
observed22,23. The textual changes are discrete and of less 
relevance23. Thus, hepatic fatty infiltration can be classified 
according to the criterion of Saadeh et al. (2002) in Grade 1 
(mild) in which the diaphragm and intrahepatic vessels are 
normally visualized, but there’re fine echoes of the 
parenchyma; Grade 2 (moderate) in which visualization of the 
intrahepatic vessels and the diaphragm are impaired and 
there’s a diffuse increase of fine echoes; Grade 3 (severe) in 
which the visualization of the intrahepatic vessels is 
diminished or absent, and the fine echoes are with a 
significant increase2,3,16. However, the ultrasound examination 
has limitations, mainly because it is a dependent 
operator6,22,25. In general, the patients who benefit most from 
the use of ultrasound are those who are thin and those who 
have low gut gas25. 
If the accumulation of lipids exceeds 10% of liver 
weight and its distribution by the organ is uniform, the 
accuracy of abdominal ultrasonography in the diagnosis of 
hepatic steatosis is between 80% and 95%12. When compared 
to biopsy, the sensitivity and specificity of the lesions are 89% 
and 93%, respectively3,16,24, so the ultrasound is very efficient 
for the diagnosis of moderate steatosis when the fat 
accumulation is higher than 33% of hepatic weight24. 
However, with the increase in the Body Mass Index, these 
values tend to decrease12. In addition, the specificity and 
sensitivity of the ultrasound examination is low in cases of 
mild steatosis1, especially when the liver has less than 33% fat 
accumulated in its parenchyma24. 
The aim of this study is to estimate the frequency of 
hepatic steatosis in a radiological clinic in Palmas-TO by means 
of a longitudinal analysis of the abdominal ultrasound 
examinations performed at the Arai Kaminishi & Costa 
imaging clinic located in Palmas in the years of 2010 and 2016. 
The benefit of this study is to provide epidemiological data on 
the prevalence of steatosis in the study population. 
METHODS 
To carry out this study, the researchers went to the 
Arai Kaminishi & Costa clinic in Palmas where they had access 
to all reports of abdominal ultrasound examinations 
performed in 3.222 and 2.346 patients in the years of 2010 
and 2016, respectively. These reports has: the name, genre 
and age of patients; the date of the examination; and the 
anatomical characteristics of the abdomen and any 
pathological alterations. Were excluded from the survey: 
individuals who didn’t have the report digitized in the clinic 
database and those whose abdomen ultrasonography reports 
didn’t contain the liver description or didn’t disclose the age 
and gender of the patients. Throughout the work, the 
participants' identity and other private information haven’t 
been disclosed while maintaining their confidentiality. This 
research also requested a dispensation of free and informed 
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consent to the Research Ethics Committee (REC)  due the fact 
that the study had a high number of participants, some of 
them no longer lived in Palmas making contact with them 
difficult and part of the data are from individuals who have 
undergone the USG exam a long time ago. Such dispensation 
was accept by REC. 
Once analyzed, pertinent data to the work were 
recorded on the researchers' laptop. This information was 
placed in four columns in the Microsoft Excel 2013 program; in 
the 1st column the patient's ages were recorded; in the 2nd, 
their genre; in the 3rd, the date of the exams; in the 4th, if 
there was any evidence leading to a suspicion of fatty filtration 
in the liver. The years 2010 and 2016 were annotated in 
separate tables for comparison and analysis of the evolution 
of the disease. 
Then, for each year, three tables were prepared to 
compare the prevalence of steatosis between the decade of 
life; one for the general population, another for the male 
population and the last one for the female population. Graphs 
were also constructed to illustrate the data obtained.  
RESULTS 
In the present study, abdominal ultrasound reports of 
3.222 individuals in the year of 2010 were analyzed which 827 
showed signs of fatty filtration in the liver and 2.395 without 
these findings giving a frequency of 25,67%. In the year of 
2016, the reports of 2.346 patients were verified which 747 
had signs of steatosis and 1.599 didn’t have them, so in that 
year the frequency was 31,84%. 
Distribution of hepatic steatosis by gender in 2010. 
Of the 3.222 people in the study in 2010, 1.128 were 
males and of these 393 had signs of steatosis, while 735 did 
not. Thus, in the male population, the frequency of hepatic 
steatosis was 34,84%. Of the 2.094 female patients, 434 
showed signs of fatty filtration in the liver and 1.660 did not, 
giving a frequency of 20,73%. Of the 827 individuals with 
hepatic steatosis, 53,48% (434 people) were female, while 
47,52% (393 people) were male (Graph 1). 
Graph 1: Distribution of hepatic steatosis by gender in 
2010. 
Distribution of hepatic steatosis by gender in 2016. 
In the year 2016, there were 2.346 individuals in the 
study, 839 were males and 1.507 females. Among men, 359 
showed signs of fatty infiltration in the liver, as 480 did not, 
giving a prevalence of 42,79% of steatosis in the male 
population. At the same time, in the female population, 388 
showed signs of steatosis and 1.119 did not, resulting in a 
prevalence of 24,75%. Of the 747 individuals with hepatic 
steatosis, 48,06% (359 people) were males, while 51,94% (388 
people) were females (Graph 2). 
Graph 2: Distribution of hepatic steatosis by gender in 
2016. 
Distribution of hepatic steatosis by age group in 
2010. 
In the year 2010, no individual from 0 to 19 years old 
was detected some finding that indicates as having steatosis, 
then the signs of infiltration began to appear from the 3rd 
decade of life (Table 1). In the male gender, signs of this 
pathology were observed only from 20 to 89 years old (Tabel 
2). In females, such signs start to appear from the age of 20 
years (Table 3). The study also showed that the number of 
individuals in 2010 with hepatic steatosis was lower at the 
extremes of age and higher at around 40-69 years old (Graph 
3). 
2010 
Age group Number With 
steatosis 
Without 
steatosis 
% with 
steatosis 
1st decade of 
life 
68 0 68 0% 
2nd decade of 
life 
141 0 141 0% 
3rd decade of 
life 
246 22 224 8,94% 
4th decade of 
life 
560 96 464 17,14% 
5th decade of 
life 
746 200 546 26,81% 
6th decade of 
life 
723 230 493 31,81% 
7th decade of 
life 
442 191 251 43,21% 
8th decade of 
life 
197 63 134 31,98% 
9th decade of 
life 
84 23 61 27,38% 
10th decade or 
more 
15 2 13 13,33% 
Total 3222 827 2395 25,67% 
Table 1: Distribution of hepatic steatosis by age group in 2010. 
2010 
Age group 
(male) 
Number With 
steatosis 
Without 
steatosis 
% with 
steatosis 
1st decade 
of life 
27 0 27 0% 
2nd decade 
of life 
68 0 68 0% 
3rd decade 
of life 
78 12 66 15,38% 
4th decade 
of life 
187 62 125 33,16% 
5th decade 257 121 136 47,08% 
359; 
48,06%
388; 
51,94%
2016
Total with hepatic steatosis: 747.
Male: 359 cases. Female: 388 cases.
393; 
47,52%
434; 
52,48%
2010
Total with hepatic steatosis: 827.
Male: 393 cases. Female: 434 cases.
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of life 
6th decade 
of life 
256 99 157 38,67% 
7th decade 
of life 
153 72 81 47,06% 
8th decade 
of life 
67 18 49 26,87% 
9th decade 
of life 
25 9 16 36% 
10th decade 
or more 
10 0 10 0% 
Total 1128 393 735 34,84% 
Table 2: Distribution of hepatic steatosis by age group in the 
male population in 2010. 
2010 
Age group 
(female) 
Number With 
steatosis 
Without 
steatosis 
% with 
steatosis 
1st decade of 
life 
41 0 41 0% 
2nd decade 
of life 
73 0 73 0% 
3rd decade 
of life 
168 10 158 5,95% 
4th decade 
of life 
373 34 339 9,12% 
5th decade 
of life 
489 79 410 16,16% 
6th decade 
of life 
467 131 336 28,05% 
7th decade 
of life 
289 119 170 41,18% 
8th decade 
of life 
130 45 85 34,62% 
9th decade 
of life 
59 14 45 23,73% 
10th decade 
or more 
5 2 3 40% 
Total 2094 434 1660 20,73% 
Table 3: Distribution of hepatic steatosis by age group in the 
female population in 2010.  
Distribution of hepatic steatosis by age group in 2016. 
In 2016, ultrasound scans detected signs of steatosis 
in people aged from 0 to 89 years (Table 4). This was also 
observed in the the male population (Table 5). In the female 
population, sights of steatosis wasn’t observed only in the 2nd 
and 10th decades (Table 6). The number of patients with 
hepatic steatosis was higher from 30 to 69 years in this 
population in 2016 (Graph 4). 
2016 
Age group Number With 
steatosis 
Without 
steatosis 
% with 
steatosis 
1st decade 
of life 
80 6 74 7,5% 
2nd decade 
of life 
106 1 105 0,94% 
3rd decade 
of life 
173 25 148 14,45% 
4th decade 
of life 
377 108 269 28,65% 
5th decade 
of life 
484 165 319 34,09% 
6th decade 568 228 340 40,14% 
of life 
7th decade 
of life 
374 166 208 44,39% 
8th decade 
of life 
132 35 97 26,52% 
9th decade 
of life 
51 13 38 25,49% 
10th decade 
or more 
1 0 1 0% 
Total 2346 747 1599 31,84% 
Table 4: Distribution of hepatic steatosis by age group in 2016. 
2016 
Age group 
(male) 
Number With 
steatosis 
Without 
steatosis 
% with 
steatosis 
1st decade 
of life 
39 1 38 2,56% 
2nd decade 
of life 
40 1 39 2,50% 
3rd decade 
of life 
65 18 47 27,69% 
4th decade 
of life 
148 69 79 46,62% 
5th decade 
of life 
178 97 81 54,49% 
6th decade 
of life 
178 91 87 51,12% 
7th decade 
of life 
120 61 59 50,83% 
8th decade 
of life 
57 17 40 29,82% 
9th decade 
of life 
13 4 9 30,77% 
10th decade 
or more 
1 0 1 0% 
Total 839 359 480 42,79% 
Table 5: Distribution of hepatic steatosis by age group 
in the male population in 2016. 
2016 
Age group 
(female) 
Number With 
steatosis 
Without 
steatosis 
% with 
steatosis 
1st decade of 
life 
41 5 36 12,20% 
2nd decade 
of life 
66 0 66 0% 
3rd decade 
of life 
108 7 101 6,48% 
4th decade 
of life 
229 39 190 17,03% 
5th decade 
of life 
306 68 238 22,22% 
6th decade 
of life 
390 137 253 35,13% 
7th decade 
of life 
254 105 149 41,34% 
8th decade 
of life 
75 18 57 24% 
9th decade 
of life 
38 9 29 23,68% 
10th decade 
or more 
0 0 0 0% 
Total 1507 388 1119 25,75% 
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Table 6: Distribution of hepatic steatosis by age group in the 
female population in 2016.  
 Graph 3: Number of people with hepatic steatosis by 
age group in the general population, in the male and the 
female in 2010. 
Graph 4: Number of people with hepatic steatosis by 
age group in the general population, in the male and the 
female in 2016. 
DISCUSSION 
In the studied population, an increase in the 
frequency of hepatic steatosis from 25,67% in 2010 to 31,84% 
in 2016 was observed, although in 2010 there was a greater 
number of participants and more individuals with signs of fatty 
infiltration in the liver compared to 2016. This shows that 
there is an increase in the cases of this pathology in this 
population. 
When comparing the distribution of steatosis 
between the gender in these two years, the frequency of this 
disease increased 
in both males (from 
34,84% to 42,79%) 
and females (from 
20,73% to 25,75%). 
The study also 
showed that when 
comparing the 
percentage of 
patients only in the 
male population, it 
was observed that 
it’s higher in both 
years than the 
percentage of 
people with 
steatosis only in 
the female 
population. 
However, in both 
2010 and 2016, 
there were more 
females with this disease than males. Thus, the hepatic 
steatosis was more frequent in women, this pattern was also 
evidenced in the literature2,5,20. 
Regarding the age group of the participants, as seen 
in the literature, the study showed that, in both periods, 
steatosis is present in a large number of patients in the 5th and 
6th decade of life2,5,20, it was also observed that the number of 
individuals with this disease was high in the 4th and 7th 
decades of life, such pattern was similar in both men and 
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women in those age groups in the two years. Differently from 
what was seen in 2010, 2016 already has signs of fatty 
infiltration in individuals from 0 to 20 years, showing that 
steatosis is starting to be present in the youngest people due 
the increase in childhood obesity in recent years12,13, and also 
the ultrasonography had an increase of the accuracy allowing 
its diagnosis in a more efficient way in the young population24. 
When comparing the total number of people with 
this pathology by the total number of individuals in the same 
age group, in 2010 the percentage is higher in the 6th, 7th and 
8th decades; in the male population of that same year, the 
percentage was higher in the 4th, 5th, 6th, 7th, 8th and 9th 
decades; while in the female population it was higher from the 
6th decade of life and forward. In 2016, the percentage was 
higher in the 5th, 6th and 7th  decades; in men was higher in the 
4th, 5th, 6th, 7th and 9th decades; in women was higher in the 6th 
and 7th decades. This fact shows that in the study population 
steatosis begins to be more present earlier in men than in 
women. 
Therefore, hepatic steatosis is a pathology that is on 
the rise in the general population, regardless of gender, even 
being present even in the pediatric population12,13. If not 
diagnosed early and treated, it can progress to other chronic 
liver diseases, such as carcinoma and cirrhosis2,6,15-18. Although 
not the "gold standard" for diagnosis, the ultrasound 
examination has a considerable accuracy to diagnose 
moderate to severe cases of steatosis24, besides being a 
cheaper and accessible test for the population, and also a non-
invasive method and doesn’t need ionizing rays for its 
realization2,24,25, thus it doesn’t offer risks to patients. 
CONCLUSION 
In the present study, in 2010 the frequency of hepatic 
steatosis in Arai Kaminishi & Costa patients was 25,67% and, 
in 2016, it increased to 31,84%. Steatosis was more frequent 
in women and in the 4th, 5th, 6th and 7th decades of life. And, 
unlike 2010, in 2016 steatosis was also found in young people. 
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